Almira
Almira Aleckovic, Anderson, SC US
Patent application number | Description | Published |
---|---|---|
20130284332 | INTEGRATED PROCESS TO GENERATE NEAR-ZERO THICKNESS SIPES IN A TIRE - The present invention comprises tire treads having sipes or other voids formed of non-curable inserts, as well as methods for forming sipes or other voids within a tread using non-curable inserts and apparatus for performing the same. Such methods include providing an uncured tread having a width and a thickness bounded by an outer side and a bottom side. Such methods further include providing a strip of non-curable material, the strip having a width and a length. Furthermore, such methods include inserting the strip of non-curable into the tread thickness from the tread outer side and to a predetermined depth within the tread thickness to form a void-forming insert within the tread thickness. Finally, these methods include curing the tread with the non-curable strip arranged within the tread thickness. The inserts may be folded, which may occur as the strips are inserted into the tread or prior to such insertion. | 10-31-2013 |
Almira Blazek-Welsh, Surrey CA
Patent application number | Description | Published |
---|---|---|
20110027342 | S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY - The invention relates to compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and to methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. The enhanced bioavailability formulations may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease. | 02-03-2011 |
Almira Blazek-Welsh, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20130142847 | S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY - Provided herein are compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. In certain embodiments, the enhanced bioavailability formulations provided herein may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease. | 06-06-2013 |